Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Changes in Stockholders' Equity (Deficit)

v3.8.0.1
Consolidated Statement of Changes in Stockholders' Equity (Deficit) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning Balance at Dec. 31, 2014 $ 29,972 $ 89,252,262 $ (91,204,764) $ (1,922,530)
Beginning Balance, Shares at Dec. 31, 2014 29,971,839      
Stock-based compensation $ 345 7,061,277   7,061,622
Stock-based compensation, Shares 344,784      
Proceeds from the sale of common stock and warrants, net of offering costs $ 11,994 37,625,965   37,637,959
Proceeds from the sale of common stock and warrants, net of offering costs, Shares 11,993,641      
Issuance of common stock from exercise of options $ 20 15,660   15,680
Issuance of common stock from exercise of options, Shares 20,000      
Issuance of common stock from exercise of warrants $ 1,736 156,204   157,940
Issuance of common stock from exercise of warrants, Shares 1,736,277      
Transfer of warrant derivatives from liability to equity classification 48,691   48,691
Net loss (21,025,314) (21,025,314)
Ending Balance at Dec. 31, 2015 $ 44,067 134,160,059 (112,230,078) 21,974,048
Ending Balance, Shares at Dec. 31, 2015 44,066,541      
Stock-based compensation $ 82 4,297,696 4,297,778
Stock-based compensation, Shares 81,700      
Proceeds from the sale of common stock and warrants, net of offering costs $ 11,504 16,011,163 16,022,667
Proceeds from the sale of common stock and warrants, net of offering costs, Shares 11,504,427      
Issuance of common stock from exercise of options $ 23 18,082 18,105
Issuance of common stock from exercise of options, Shares 23,212      
Issuance of common stock from exercise of warrants $ 126 (126)
Issuance of common stock from exercise of warrants, Shares 125,862      
Transfer of warrant derivatives from liability to equity classification 17,455 17,455
Net loss (24,321,724) (24,321,724)
Ending Balance at Dec. 31, 2016 $ 55,802 154,504,329 (136,551,802) 18,008,329
Ending Balance, Shares at Dec. 31, 2016 55,801,742      
Stock-based compensation $ 93 3,474,282 3,474,375
Stock-based compensation, Shares 93,385      
Proceeds from the sale of common stock and warrants, net of offering costs $ 24,173 18,765,461 18,789,634
Proceeds from the sale of common stock and warrants, net of offering costs, Shares 24,172,973      
Issuance of common stock from exercise of warrants $ 4 (4)
Issuance of common stock from exercise of warrants, Shares 4,234      
Net loss (26,601,235) (26,601,235)
Ending Balance at Dec. 31, 2017 $ 80,072 $ 176,744,068 $ (163,153,037) $ 13,671,103
Ending Balance, Shares at Dec. 31, 2017 80,072,334